-transparent.png){kind=logo}
BALB/c mice immunized with syngeneic methylcholanthrene-induced fibrosarcomas did not have antibodies against the unique tumor-specific transplantation antigens, even though they were capable of rejecting a lethal dose of tumor cells. Endogenous murine leukemia virus antigens expressed by certain of the tumors did, however, elicit high titers of antibodies, accounting for serological crossreactions that occurred between those tumors.
Related Publications
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
July 1964,
Cancer research,
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
September 1958,
Annals of the New York Academy of Sciences,
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
January 1976,
Surgical forum,
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
September 1958,
Annals of the New York Academy of Sciences,
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
July 1974,
International journal of cancer,
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
March 1977,
Investigative urology,
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
May 2006,
Proceedings of the National Academy of Sciences of the United States of America,
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
March 1974,
Journal of the National Cancer Institute,
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
September 2016,
Medical science monitor : international medical journal of experimental and clinical research,
J P Brown, and
J M Klitzman, and
I Hellström, and
R C Nowinski, and
K E Hellström
January 1958,
Advances in cancer research,
